700PSTAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer
Volume
30
Pagination
v267 - ?
DOI
10.1093/annonc/mdz247.027
Journal
Annals of Oncology
Issue
ISSN
0923-7534